Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-046899 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
14,632
Total Value
$29,682.81
P&L
-10.8% ($3,198.89)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 8, 2026 | Purchase | 2,077 | $2.02 | $4,190.35 | 2,860,734 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 9, 2026 | Purchase | 5,340 | $2.04 | $10,918.16 | 2,866,074 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 12, 2026 | Purchase | 7,215 | $2.02 | $14,574.30 | 2,873,289 | Indirect | By Opaleye, L.P. | View Details |